Skip to main content
Log in

NC 100150

(Clariscan™, PEG-Ferron)

  • Research Review
  • Adis R&D Profile
  • Published:
Drugs in R & D Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Table I
Table II

Notes

  1. 1This profile has been selected from R&D Insight™, a pharmaceutical intelligence database produced by Adis International Ltd.

References

  1. Turetschek K, Huber S, Helbich T, Floyd E, Tarlo KS, et al. Dynamic MRI enhanced with albumin-(Gd-DTPA) (30) or ultrasmall superparamagnetic iron oxide particles (NC100150 injection) for the measurement of microvessel permeability in experimental breast tumors. Academic Radiology. 9 (Suppl 1): 112–114, May 2002. Univiversity of California San Francisco, San Francisco, California, USA

    Article  Google Scholar 

  2. Hilfiker PR, Zimmermann-Paul GG, Schmidt M, et al. Intestinal and peritoneal bleeding: detection with an intravascular contrast agent and fast three-dimensional MR imaging — preliminary experience from an experimental study. Radiology. 209: 769–774, No. 3, 1998

    PubMed  CAS  Google Scholar 

  3. Johansson LO, Nolan MM, Lorenz CH. High resolution magnetic resonance coronary angiography of the entire heart using a new blood-pool agent NC100150 injection: comparison with X-ray angiography. Circulation. 98 (Suppl): 514, 27 Oct 1998

    Google Scholar 

  4. Wagenseil JE, Johansson LOM, Lorenz CH. Characterization of T1 relaxation and blood-myocardial contrast enhancement of NC100150 injection in cardiac MRI. Journal of Magnetic Resonance Imaging. 10: 784–789, Nov 1999

    Article  PubMed  CAS  Google Scholar 

  5. Johansson LO, Bjerner T, Bjornerud A, Ahlstrom H, Tarlo KS, et al. Utility of NC100150 injection in cardiac MRI. Academic Radiology. 9 (Suppl 1): 79–81, May 2002. Nycomed Imaging AS, Oslo, Norway

    Article  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

NC 100150. Drugs R&D 3, 303–304 (2002). https://doi.org/10.2165/00126839-200203050-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00126839-200203050-00002

Keywords

Navigation